Currently we are engaged in different projects with various small, medium and global companies, institutes, universities and other scientific agencies. For confidentiality reasons we are not able to divulge some of these partners at this point in time.
Adtec Healthcare Ltd.
With the company Adtec Healthcare Ltd. we have a longstanding cooperation, which started several years ago at the Max Planck Institute for Extraterrestrial Physics. In close cooperation we developed a cold atmospheric plasma device for the treatment of chronic infected wounds – the “MicroPlaSter” – now “SteriPlas - which was tested extensively in clinical studies for over 8 years. The plasma technology was sub-licensed to Adtec Healthcare Ltd. who market and sell the device since August 2015.
Further details can be found under: www.adtecplasma.com
In cooperation with the company Blümchen AG we developed an extractor hood with an integrated plasma source. Using our newly developed plasma technologies we can very efficiently inactivate odour molecules of any kind. This project was supported by the “Central innovation program for medium-sized companies” (Zentrales Innovationsprogramm Mittelstand) of the Federal Ministry of Economics and Technology.
Further details can be found under: www.bluemchen-ag.eu
Supported by: Federal Ministry for Economic Affairs and Energy based on a decision of the German Bundestag
Bundeswehr Research Institute for Protective Technologies and NBC Protection (WIS)
The military use of biological weapons jeopardises our troops and can also negatively affect the function of used military equipment, materials or other systems leading to various failures. In the project “Development of a decontamination chamber using cold atmospheric plasma” for sterilization of thermolabile equipment this problem was addressed. Target of our studies within this project was to develop a mobile chamber for sterilisation of thermolabile equipment for military use. WIS represents an area of expertise within the Federal Office of Bundeswehr Equipment, Information Technology and In-Service Support (BAAINBw).
Further details can be found under: www.baainbw.de
European Space Agency (ESA)
Together with ESA, the project „A cold plasma device to support future manned spaceflight“ is investigating into the potential of cold plasma technology for various applications in manned space travel. The focus of these studies is currently on the removal of bacteria and odors in clothing as well as on the production of drinking water.
Georg-August University Göttingen
In cooperation with the Department of Otorhinolaryngology, Head & Neck Surgery of the Georg-August-University in Göttingen we are currently investigating the effect of cold atmospheric plasma – produced with the Surface Micro-Discharge technology – on head & neck cancer. The target of this joint project is to develop a cold plasma source, which slows down growth and kills head & neck cancer cells without harming healthy mucosa.
Further details can be found under: www.med.uni-goettingen.de
German Aerospace Center – research unit „complex plasmas“
In a joint project – funded by the Bavarian Department of Commerce – terraplasma together with the German Aerospace Center and the University Gießen developed a new cold atmospheric plasma setup for the decontamination of sensitive space flight components.
Further details of our cooperation partners:
German Aerospace Center – Space Agency
In the project „Investigation of a handheld device for plasma disinfection“ – funded by the Space Agency of the German Aerospace Center – a small and mobile cold plasma device for the treatment of smaller wounds and skin diseases under zero gravity was developed.
Institute of Pathology at the Technical University of Munich, Germany
At the Institute of Pathology at the Technical University of Munich, Germany the effect of cold atmospheric plasma on molecular and cell biological level is researched under the supervision of Prof. Dr. med. Jürgen Schlegel. In particular, the experts investigate the following two areas:
- Effectiveness of cold atmospheric plasma for the treatment of in vitro rat glioblastoma cells (brain tumour cells) in combination with ionizing radiation – the aim is to substantially progress in tumour therapy research
- Influence of cold atmospheric plasma on the proliferation and differentiation of muscular stem cells of mice and humans on a molecular level – the aim is to better understand the mode of action of cold atmospheric plasma on molecular level
Further details can be found under: http://www.path.med.tum.de/
University Hospital Regensburg
In cooperation with the University Regensburg we are currently developing a medical plasma source based on the thin film technology. This plasma source is tested in preclinical investigations and evaluated by carrying out different biomedical and biological tests. The aim of this project is to define suitable plasma parameters for inactivating bacteria without harming eukaryotic cells or tissue. The definition of a safe therapeutic window is an essential prerequisite for the further development of the plasma electrode to a medical product class II a.
Funded by the scientific program “medical technology” (BayMED) of the Bavarian Ministry of Economic Affairs and Media, Energy and Technology.
Further information can be found under: www.uniklinikum-regensburg.de
University of Veterinary Medicine Hannover
In cooperation with the Institute for Food Quality and Food Safety of the University of Veterinary Medicine Hannover we are currently working on the development of a cold atmospheric plasma device for the decontamination of meat products. The aim of this joint project includes the investigation of the influence of cold atmospheric plasma on microbiological, physical and chemical as well as sensory parameters of processed meat.
Further information can be found under: www.tiho-hannover.de